Log in to save to my catalogue

Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leu...

Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9899623

Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia

About this item

Full title

Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2023-02, Vol.114 (2), p.596-605

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

This prospective phase I trial aimed to determine the recommended dose of 3‐day total marrow and lymphoid irradiation (TMLI) for a myeloablative conditioning regimen by increasing the dose per fraction. The primary end‐point of this single‐institution dose escalation study was the recommended TMLI dose based on the frequency of dose‐limiting toxici...

Alternative Titles

Full title

Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9899623

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9899623

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.15611

How to access this item